Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Van Elle bid and ex-dividends

AIM movers: Greatland Resources reaches share price high and Sunda Energy diversifies into New Zealand

AIM movers: Haydale subsidiary wins water contract and InsigAI continues to rise on back of potential Nasdaq listing

Why companies left AIM in March 2026

Why companies left AIM in February 2026

Why companies left AIM in January 2026

AIM weekly movers: Greatland Resources updates mineral estimates

Aquis weekly movers: Probiotix Health moving into profitability

AIM movers: Coro Energy secures debt facility and ex-dividends

AIM movers: Deltic Energy bid lapses and Insig AI considers Nasdaq listing

AIM movers: Ironveld share trading recommences as it seeks funds and BRCK approach

AIM movers: Abingdon Health wins US contracts and Mirriad Advertising running out of cash

Director deals: Adam Kaye buys Everyman shares after Omniplex stake purchase

Aquis weekly movers: Connecting Excellence increases net fee income

AIM movers: Burford Capital case judgement overturned

AIM movers: Stakebuilding in Everyman Media and Switch Metals MRE delayed

AIM movers: Checkit seeks interest from bidders and ex-dividends

AIM movers: Volex beats estimates and Seascape Energy Asia cash call

AIM movers: Weak fourth quarter for Distil and Clean Power Hydrogen deal with Siemens

AIM movers: Eroxon Intense hope for Futura Medical and further cash outflow for Blackbird

Director deals: Finance director takes advantage of Dotdigital share price fall

AIM weekly movers: Strategic Metals raises cash and improves Redmoor recoveries

Aquis weekly movers: S-Ventures plans UAV acquisition

Vista Parcs launches retail offer to help fund residential parks purchase

AIM movers: TheWorks.co.uk ending online sales and Sound Energy raises cash at big discount

AIM movers: Strategic Minerals raises cash for Redmoor in Cornwall and ex-dividends

AIM movers: itim hit by Quiz loss and another Ramsdens upgrade

AIM movers: ImmuPharma cash raising and CRISM Therapeutics orphan designation

AIM new admission: Lord Ashcroft floats Africa investor Tapir

AIM movers: River Global selling asset management business and DSW hit by postponed M&A

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020